Source: Global Legal Chronicle

PeproTech: Thermo Fisher Scientific's $1.85 Billion Acquisition of PeproTech

Foley Hoag represented Thermo Fisher Scientific in the acquisition. On December 30, 2021, Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc., [...]

Read full article »

PeproTech's Competitors | PeproTech's News | PeproTech's Financials

Followers on Owler

381

Est. Annual Revenue

$25-100M

Est. Employees

100-250

President

Robert Goldman

CEO Approval Rating

62/100

PeproTech is a New Jersey-based company that manufactures and markets recombinant proteins and polyclonal antibodies for the biotech and life science industries.